Form 8-K - Current report:
SEC Accession No. 0001731122-25-001399
Filing Date
2025-10-16
Accepted
2025-10-16 15:21:09
Documents
13
Period of Report
2025-10-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e6960_8-k.htm   iXBRL 8-K 28253
2 EXHIBIT 99.1 e6960_ex99-1.htm EX-99.1 4088
  Complete submission text file 0001731122-25-001399.txt   199122

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lnai-20251015.xsd EX-101.SCH 2990
4 XBRL LABEL FILE lnai-20251015_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE lnai-20251015_pre.xml EX-101.PRE 22342
15 EXTRACTED XBRL INSTANCE DOCUMENT e6960_8-k_htm.xml XML 3690
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Lunai Bioworks Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 251397504
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)